हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।
ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं
John A Smith, Emily B Johnson
This article provides a comprehensive overview of the research advancements in understanding and intervening in BRCA gene mutations associated with breast cancer. The discovery of BRCA1 and BRCA2 genes marked a pivotal moment in cancer genetics, unraveling the genetic landscape of hereditary breast and ovarian cancers. Over the years, diagnostics, risk assessment strategies, and targeted therapies have evolved, significantly impacting patient care and outcomes. This article highlights the progress made in this field, discusses challenges, and outlines future directions for research and interventions aimed at mitigating the impact of BRCA gene mutations on breast cancer. Over the years, extensive research has shed light on the genetic underpinnings of breast cancer, particularly mutations in the BRCA1 and BRCA2 genes. These mutations are associated with a significantly increased risk of developing breast and ovarian cancers. The journey of understanding and intervening in BRCA gene mutations has been a dynamic one, marked by breakthroughs in genetics, diagnostics, and targeted therapies. This article provides an overview of the research progress in advancing our understanding of BRCA gene mutations and the interventions developed to combat associated breast cancer risks